Tag Archives: CRBN

24Mar/21

PROTAC, a Frontier Small Molecule Drug

March 24, 2021PROTAC Research, protac reviewsArvinas, CRBN, E3 ligase, protac, VHLbiolabs

On December 14, 2020, Arvinas, a pioneer of PROTAC, announced the results of phase I clinical trials of new PROTAC drugs ARV-471 and ARV-110, of which ARV-471 showed outstanding efficacy in patientsRead More…

13Oct/20

Basic Research Progress of PROTAC in Hematological Diseases-Part Two

October 13, 2020PROTAC News, PROTAC ResearchAcute Myeloid Leukemia, B cell lymphoma, CRBN, linker, protacbiolabs

In addition to the T-cell Lymphoma,T-cell Acute Lymphoblastic Leukaemia mentioned in our previous article, there are also related studies of protac in other blood diseases. Next, let’s analyze the research of protacRead More…

PROTAC Research
PROTAC News